Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)

Supplemental material

Files in this Data Supplement:

• Supplemental file 1 -

  Activities of ASV in combination with BMS‐791325 (Table S1), HCV‐796 (Table S2), and NM‐107 (Table S3); triple combination studies using ASV, daclastavir, and rIFNα (Table S4); triple combination studies using ASV, BMS‐791325, and rIFNα (Table S5); three‐dimentional synergy plot representing MacSynergy combination analysis of ASV with ribavirin (Fig. S1).

  PDF, 149K